Business Description
SCYNEXIS Inc
NAICS : 325412
SIC : 2834
ISIN : US8112921015
Description
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.33 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -0.45 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -4.92 | |||||
| Beneish M-Score | -1.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 19.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 84.45 | |||||
| 9-Day RSI | 67.2 | |||||
| 14-Day RSI | 56.91 | |||||
| 6-1 Month Momentum % | -36.65 | |||||
| 12-1 Month Momentum % | -10.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.13 | |||||
| Quick Ratio | 3.13 | |||||
| Cash Ratio | 2.68 | |||||
| Days Inventory | 290.88 | |||||
| Days Sales Outstanding | 97.79 | |||||
| Days Payable | 148.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -23.7 | |||||
| Shareholder Yield % | 37.48 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -71.42 | |||||
| Operating Margin % | -608.57 | |||||
| Net Margin % | -425.41 | |||||
| FCF Margin % | -254.93 | |||||
| ROE % | -50.9 | |||||
| ROA % | -30.26 | |||||
| ROIC % | -142.3 | |||||
| ROC (Joel Greenblatt) % | -1268.04 | |||||
| ROCE % | -36 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 9.06 | |||||
| PS Ratio | 7.7 | |||||
| PB Ratio | 0.89 | |||||
| Price-to-Tangible-Book | 0.89 | |||||
| EV-to-EBIT | 0.03 | |||||
| EV-to-EBITDA | 0.03 | |||||
| EV-to-Revenue | -0.11 | |||||
| EV-to-FCF | 0.04 | |||||
| Price-to-Net-Current-Asset-Value | 1.3 | |||||
| Price-to-Net-Cash | 1.83 | |||||
| Earnings Yield (Greenblatt) % | 3333.33 | |||||
| FCF Yield % | -42.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SCYX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SCYNEXIS Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8.566 | ||
| EPS (TTM) ($) | -0.76 | ||
| Beta | 1.79 | ||
| Volatility % | 74.9 | ||
| 14-Day RSI | 56.91 | ||
| 14-Day ATR ($) | 0.07863 | ||
| 20-Day SMA ($) | 1.27425 | ||
| 12-1 Month Momentum % | -10.26 | ||
| 52-Week Range ($) | 1.15 - 3.07 | ||
| Shares Outstanding (Mil) | 37.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SCYNEXIS Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SCYNEXIS Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
SCYNEXIS Inc Frequently Asked Questions
What is SCYNEXIS Inc(SCYX)'s stock price today?
The current price of SCYX is $1.37. The 52 week high of SCYX is $3.07 and 52 week low is $1.15.
When is next earnings date of SCYNEXIS Inc(SCYX)?
The next earnings date of SCYNEXIS Inc(SCYX) is 2025-03-28 Est..
Does SCYNEXIS Inc(SCYX) pay dividends? If so, how much?
SCYNEXIS Inc(SCYX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers